(Page 6)

August 27, 2021 UVA Earns Comprehensive Cancer Center Designation

University of Virginia Cancer Center has been awarded a Comprehensive Cancer Center designation effective Feb. 1, 2022, by the National Cancer Institute (NCI), the largest funder of cancer research in the world.

August 18, 2021 Blood-Pressure Drugs Could Improve Colorectal Cancer Survival

ACE inhibitors, beta-blockers and thiazide diuretics were all associated with decreased mortality in patients with colorectal cancer.

August 11, 2021 UVA Discovery Suggests Potential New Treatment for Deadly Blood Cancer

A drug used to treat certain advanced breast cancers may offer a new treatment option for a deadly blood cancer known as myelofibrosis, new research from UVA Cancer Center suggests.

July 28, 2021 Centra and UVA Health Announce Strategic Clinical Affiliation, Building on a Shared Commitment to Quality Care in the Local Community

Building on each other’s strengths in delivering highly specialized patient care, Centra and UVA Health are pleased to announce a strategic clinical affiliation to increase access to advanced health care and innovative treatments close to home, furthering their long-standing commitment to the local community.

June 4, 2021 Colorectal Cancer: UVA Health Expert Helps Develop New National Screening Guidelines

Most Americans should get screened for colorectal cancer beginning at age 45 instead of age 50, according to new recommendations from the U.S. Preventive Services Task Force, which includes UVA Health’s Li Li, MD, PhD, MPH.

May 25, 2021 UVA Cancer Center, Other Top U.S. Cancer Centers Urge Cancer-Preventing HPV Vaccinations

UVA Cancer Center is joining 70 other National Cancer Institute (NCI)-designated cancer centers and partner organizations in urging physicians, parents and young adults to get cancer-preventing human papillomavirus (HPV) vaccinations back on track.

May 24, 2021 UVA Develops New Tools to Battle Cancer, Advance Genomics Research

A new website, bartcancer.org, can provide “unique insights” for cancer researchers, its creators say.

May 4, 2021 UVA’s Dr. Michael E. Williams Honored Nationally for Improving Lymphoma Care

For his work to improve patient care and develop new therapies for mantle cell lymphoma (MCL), the Lymphoma Research Foundation honored UVA Health’s Michael E. Williams, MD, this month with the Mantle Cell Lymphoma Leadership Award.

March 31, 2021 Stem Cell Transplants Prevent Relapses of Most Common Childhood Cancer

UVA researchers identify a way to prevent relapses in children who receive CAR T-cell therapy for acute lymphoblastic leukemia.

March 30, 2021 Lung Cancer: UVA Health Expert Helps Develop New National Screening Guidelines

Through his role on the U.S. Preventive Services Task Force, UVA Health’s Li Li, MD, PhD, MPH, has helped develop new lung cancer screening guidelines that expand screenings to more high-risk patients.